Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/07/23 08:31:00 on US and Canada Markets.
New Patent Extends Intellectual Property Footprint for Company’s Groundbreaking Technology in Large ECG Patch Monitor Market HeartBeam, In c. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size, portable 3D-vector electrocar...
Agreement Includes Continuation of Bragg as Exclusive Supplier of Content and Product Delivery Services to the Leading Dutch Sportsbook and Casino Operator Bragg Gaming Group Inc. ( NASDAQ: BRAG , TSX: BRAG ) (“ Bragg ” or the “ Company ”), ...
NEW YORK , NY / ACCESSWIRE / November 7, 2023 / The Glimpse Group , Inc. ("Glimpse") (NASDAQ:VRAR) (FSE:9DR), a diversified Immersive technology platform company providing enterprise-focused Virtual Reality ("VR"), Augmented Reality ("AR") and Spatial Computing software and services, will r...
HALIFAX, NS / ACCESSWIRE / November 7, 2023 / Meta Materials Inc. (the "Company" or "META") (NASDAQ:MMAT), an advanced materials and nanotechnology company, today announced preliminary positive cost cutting results from the initial stages of restructuring, while signaling its intent to focus on ...
EpicQuest Education's Davis College Announces Two New Agreements PR Newswire EEIQ is Committed to its Mission of Internalization which Expands its Academic Programming and Bolsters Enrollment MIDDLETOWN, Ohio , Nov. 7, 2023 /PRNewswire/ -- EpicQuest Educa...
NEW YORK, NY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Elys Game Technology, Corp. (“Elys” or the “Company”) (OTC:ELYS) (BER:3UW), an interactive gaming and sports betting technology company, today announced a market access agreement with Caesars Entertainment that unlock...
– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 – – Topline data readouts from ongoing Phase 1/2 trials of INZ-701 in adults with ABCC6 Deficiency and ENPP1 Deficiency ex...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00am Eastern Time on Monday, November 20, 2023, to review thi...
CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces today that the first patient in the Phase 1a...
DUBLIN, Ireland and CHICAGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.48%Change Percent:
Procore Technologies Inc. Company Name:
PCOR Stock Symbol:
NYSE Market:
procore.com Website: